SRDX News and Press, Surmodics Inc. From 04/24/19

Webcast is Live at 4 p.m. (CT) Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that it will host a live webcast of its second quarter fiscal 2019 conference call on Wednesday, May 1...

Guide sheath is the first of Surmodics’ family of products designed for peripheral procedures accessed from the radial artery Surmodics, Inc. (NASDAQ:SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, announced it has r...

Surmodics, Inc. (NASDAQ: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, has resumed patient enrollment into its TRANSCEND clinical trial and is nearly 75 percent of the way to its goal of 446 randomized patients. Patient ...

The following slide deck was published by Surmodics, Inc. in conjunction with this Read more ...

Webcast is Live on Wednesday, April 10, at 1:30 p.m. (ET) Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that Gary Maharaj, president and chief executive officer, and Tim Arens, vi...

Thinly traded Surmodics ( SRDX -8.4% ) is down on average volume, albeit turnover of only 89K shares, in response to its disclosure of an updated FDA advisory on the potential for higher rates of long-term mortality connected to the use of paclitaxel-coated balloons and paclitaxel-elutin...

Surmodics (NASDAQ: SRDX ) has named  Timothy J. Arens, Vice President of Corporate Development and Strategy, as the company’s new CFO, effective immediately. More news on: Surmodics, Inc., Read more ...

Surmodics, Inc. (NASDAQ: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced the appointment of Timothy J. Arens, Vice President of Corporate Development and Strategy, as the company’s new Chief Financi...

Virtual Meeting on February 13 at 4 p.m. (CT) Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, will hold its Annual Meeting of Shareholders on Wednesday, February 13, at 4 p.m. CT (5:...

Surmodics, Inc. (SRDX) Q1 2019 Earnings Conference Call January 30, 2019 05:00 PM ET Company Participants Tim Arens - VP, Corporate Development & Strategy, Interim VP, Finance and CFO Gary Maharaj - CEO, President & Director Conference Call Participants David Saxon - ...